During the past year treatment with the bioflavonoids has been widely publicized as a means of preventing or modifying the common cold. One of the reasons given for the effect has been that they potentiated ascorbic acid (vitamin C) in alleviating cold symptoms. Since there was no convincing proof available, either in support or in denial, we undertook a pilot study to explore the validity of these statements. Within the limits of this study, the bioflavonoid tested showed effect neither on the incidence or cure of colds nor on the ascorbic acid content of the blood. In the course of the study, interesting data \vere developed regarding the relationship of blood ascorbic acid levels to the incidence and cure of colds. These are reported in detail.
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Method
The study was made on 89 volunteer medical students and student nurses for the three-month period from February to May, 1956 . Four groups were established and given capsules (three times daily, From the Dartmouth Medical School and the Hitchcock Foundation.
• The incidence and course of common colds were followed in 89 medical students and nurses who volunteered Patients Given Placebo and tasted alike. Even the doctors conducting the study did not know the key to the code numbers used. Groups were assigned in rotation. Thus the first volunteer in line received bland placebo, the second naringin (bioflavonoid) and ascorbic acid, and the fifth bland placebo, as the rotation started over again. Each subject received a regional physical examination and had blood taken for a determination of ascorbic acid level the day he started the study. All the volunteers were started on the regimen within a single week. Thereafter they continued taking their particular capsule for the three months of the study. At the 6-Aveek and 12-week points in the study, determinations of blood ascorbic acid level were made on all 89 participants. The subject was instructed to report cold symptoms (such as coryza, headache, malaise, fever, or sore throat) the day of onset. At this time the physical examination and determination of blood ascorbic acid level were repeated. He was asked to take no specific cold remedies, not even aspirin or nasal sprays, during the course of the infection. He continued taking the same dosage of the capsule assigned to his group. No antibiotics were used. During the infection the same physician made a record (daily when possible) of the cold's progress or regression. On the fifth day the cold was evaluated as cured, improved, unchanged, or worse.
Two variables were accepted as calculated risks to the accuracy of the study: diet and individual reliability. Although the majority of the subjects ate in the same hospital cafeteria, precise control of their diet was felt to be beyond the scope of this essentially pilot study. We recognized, of course, the varying ele- grees of reliability with which 89 persons would take 3 capsules a day for three months; we believe, however, that close supervision and the medical orientation of the participants kept this factor of error at a minimum. Tables 1, 2 , 3, and 4 give the detailed blood ascorbic acid levels accumulated during this study. They are included in their complete form, partly because they are the basis for the conclusions of this pilot study and partly because comparable records of blood ascorbic acid levels in normal young adults are relatively rare. (Ascorbic acid blood levels were determined according to the technique of Roe and Kuether 1 under the supervision of John P. Davison, Ph.D., assistant professor of the physiological sciences in the Dartmouth Medical School.) Table 5 summarizes the effectiveness of bioflavonoid with and without ascorbic acid. When used alone, it produced the same results as a placebo. When used with ascorbic acid, the results were comparable to those with ascorbic acid alone. Table 6 indicates that the prolonged administration of bioflavonoid had no effect on the blood ascorbic acid level. Females consistently showed a higher blood ascorbic acid level than males (table 6-statistically significant at the 0.01 level). Most of those receiving ascorbic acid showed an increased blood ascorbic acid level. Those receiving ascorbic acid developed just as many colds as those not receiving it (table 5). In this small series, those receiving ascorbic acid showed more rapid improvement in their colds th-in those not receiving it (tables 1 to 5 inclusive-statistically significant at the 0.05 level). Comment Ascorbic acid deficiencies have been noted not only in classic scurvy but in other infectious and metabolic disorders, such as rheumatoid arthritis, rheumatic Patients Given Bioflaconoid fever, tuberculosis, and certain virus infections. The importance of ascorbic acid in maintaining capillary integrity has long been recognized. We will discuss neither the related background nor the literature. Recently certain naturally occurring substances have been found to have a related function in maintaining the integrity of the intercellular cement substance. The materials as a group have been classified as fluvone glycosides and include such substances as hesperidin, rutin, and naringin. We are particularly concerned with those substances derived from citrus fruit peels, grouped together under the title of bioflavonoids. The significant literature on this subject was summarized at a meeting of the New York Academy of Sciences in 1955, which is reported in the annals of that organization." Various articles in this monograph suggest a relationship between ascorbicacid and the bioflavonoids, with particular reference to their effects on capillary fragility. The monograph also reports the clinical use of the bioflavonoids and ascorbic acid in the treatment of disorders related to decreased capillary permeability. These include poliomyelitis, rheumatic fever, and bleeding related to pregnancy. The hypothesis that the bioflavonoids may prevent or modify colds is apparently based on this same property.
Results
With this possibility in view, a number of drug compounds appeared on the market during the winter of 1955-1956 featuring a bioflavonoid content. Most of these compounds also contained such old cold treatment stand-bys as aspirin, caffeine, and ascorbic acid. The limited statements regarding this treatment of colds reported the use of the whole compound, without reference to specific studies based on the effect of the bioflavonoid alone.
We are reporting a pilot study on the effectiveness of one bioflavonoid per se. It is, of course, not defini- tive. But, in the absence of any comparable evaluation of a material whose commercial distribution is already widespread, we feel that even this limited study may be helpful to the medical profession. The approximately 300 determinations of blood ascorbic acid level were a by-product of the bioflavonoid study. The series is far too small to warrant conclusive interpretations, but the data raise several points of interest that may serve as points of departure in more definitive studies. 
Summary
We are reporting a controlled pilot study of the clinical effect of bioflavonoids and ascorbic acid (vitamin C) on the incidence and cure of the common cold, correlated with serial determinations of blood ascorbic acid level on the 89 medical students and student nurses comprising the test group. The administration of a bioflavonoid had effect neither on the incidence or cure of colds nor on the ascorbic acid level of the blood.
